Literature DB >> 18403020

Role of STAT3 in glucocorticoid-induced expression of the human IL-10 gene.

Claudia Unterberger1, Karl J Staples, Timothy Smallie, Lynn Williams, Brian Foxwell, Annette Schaefer, Bettina Kempkes, T P J Hofer, Max Koeppel, Marion Lohrum, Henk Stunnenberg, Marion Frankenberger, Loems Ziegler-Heitbrock.   

Abstract

In the present report we have determined the molecular mechanisms, which govern the expression of the human IL-10 gene when induced by the glucocorticoid Methyl-Prednisolone (MP). Treatment of cells with MP at 10(-6) M will readily induce IL-10 in CD19+ primary B cells and in a human B cell line. Analysis of the IL-10 promoter showed a robust 18-fold induction and demonstrated that a potential GRE motif was not required, while mutation of the -120 STAT-motif strongly reduced MP-induced trans-activation. A strong induction was also seen with a trimeric STAT-motif and over-expression of dominant-negative STAT3 could block MP induction of IL-10 mRNA. Finally, MP treatment induced binding of STAT3 to the promoter as shown by gelshift, supershift and by chromatin-immunoprecipitation. These data show that glucocorticoid-induced expression of the IL-10 gene is mediated by the transcription factor STAT3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403020     DOI: 10.1016/j.molimm.2008.02.020

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  12 in total

1.  The role of regulatory B cells in Echinococcus granulosus-infected mice.

Authors:  Xinwei Qi; Jiaoyu Shan; Xuelei Liu; Bin Li; Xuanlin Cai; Xuemei Liu; Jie Lv; Xuan Zhou; Madinaimu Aibibula; Xiumin Ma
Journal:  Parasitol Res       Date:  2021-02-01       Impact factor: 2.289

2.  Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression.

Authors:  Claude A Piantadosi; Crystal M Withers; Raquel R Bartz; Nancy Chou MacGarvey; Ping Fu; Timothy E Sweeney; Karen E Welty-Wolf; Hagir B Suliman
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

3.  5α-reduced glucocorticoids exhibit dissociated anti-inflammatory and metabolic effects.

Authors:  C Yang; M Nixon; C J Kenyon; D E W Livingstone; R Duffin; A G Rossi; B R Walker; R Andrew
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

4.  Oral glucocorticoid treatment decreases interleukin-10 receptor expression on peripheral blood leucocyte subsets.

Authors:  M Moniuszko; A Bodzenta-Lukaszyk; M Dabrowska
Journal:  Clin Exp Immunol       Date:  2009-03-09       Impact factor: 4.330

Review 5.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

6.  Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner.

Authors:  Renate Louw-du Toit; Janet P Hapgood; Donita Africander
Journal:  J Biol Chem       Date:  2014-09-08       Impact factor: 5.157

7.  FGFR4 polymorphic variants modulate phenotypic features of Cushing disease.

Authors:  Tae Nakano-Tateno; Toru Tateno; Maw Maw Hlaing; Lei Zheng; Katsuhiko Yoshimoto; Shozo Yamada; Sylvia L Asa; Shereen Ezzat
Journal:  Mol Endocrinol       Date:  2014-03-13

Review 8.  Interleukin-10: new perspectives on an old cytokine.

Authors:  David M Mosser; Xia Zhang
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

9.  Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users.

Authors:  Léanie Kleynhans; Nelita Du Plessis; Gillian F Black; André G Loxton; Martin Kidd; Paul D van Helden; Gerhard Walzl; Katharina Ronacher
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

10.  Viral infection increases glucocorticoid-induced interleukin-10 production through ERK-mediated phosphorylation of the glucocorticoid receptor in dendritic cells: potential clinical implications.

Authors:  Sinnie Sin Man Ng; Andrew Li; George N Pavlakis; Keiko Ozato; Tomoshige Kino
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.